These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3284103)

  • 1. Interaction of calcium blockers and cyclosporine.
    Wagner K; Henkel M; Heinemeyer G; Neumayer HH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):561-8. PubMed ID: 3284103
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the calcium channel blocker diltiazem on cyclosporine A blood levels and dose requirements.
    Kohlhaw K; Wonigeit K; Frei U; Oldhafer K; Neumann K; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):572-4. PubMed ID: 3284105
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels.
    Bach JF; Feutren G; Noel LH; Hannedouche T; Landais P; Timsit J; Boitard C; Bougnères P; Boitard C; Grünfeld JP
    Transplant Proc; 1990 Jun; 22(3):1296-8. PubMed ID: 2349690
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of Nva2-cyclosporine on glomerular filtration rate and renal blood flow in the rat.
    Paller MS; Ferris TF
    Transplantation; 1987 Jun; 43(6):893-5. PubMed ID: 3590301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An appraisal of drug interactions with Sandimmun.
    Cockburn IT; Krupp P
    Transplant Proc; 1989 Oct; 21(5):3845-50. PubMed ID: 2683269
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period.
    Lloveras JJ; Durand D; Ader JL; Tran Van T; Rostaing L; Cerene A; Fournial G; Suc JM
    Transplant Proc; 1993 Jun; 25(3):2226. PubMed ID: 8516879
    [No Abstract]   [Full Text] [Related]  

  • 7. The cyclosporine-sparing effects of diltiazem in renal transplantation.
    McCauley J; Ptachcinski RJ; Shapiro R
    Transplant Proc; 1989 Dec; 21(6):3955-7. PubMed ID: 2609415
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective serial renal function studies in patients with nonrenal disease treated with cyclosporine A.
    Tegzess AM; Doorenbos BM; Minderhoud JM; Donker AJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):530-3. PubMed ID: 3388497
    [No Abstract]   [Full Text] [Related]  

  • 9. Biologic significance of cyclosporine metabolites.
    Ryffel B; Foxwell BM; Mihatsch MJ; Donatsch P; Maurer G
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):575-84. PubMed ID: 3363656
    [No Abstract]   [Full Text] [Related]  

  • 10. Japanese conference on cyclosporine blood level monitoring.
    Takagi H; Uchida K
    Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
    [No Abstract]   [Full Text] [Related]  

  • 11. Concomitant immunosuppressive and antibiotic therapy--reduction of cyclosporine A blood levels due to treatment with imipenem/cilastatin.
    Mraz W; Sido B; Knedel M; Hammer C
    Transplant Proc; 1987 Oct; 19(5):4017-20. PubMed ID: 3478881
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine and urinary prostaglandins.
    Kho TL; Teule J; Leunissen KM; Heidendahl GA; Lijnen P; Amery A; van Hooff JP
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):650-3. PubMed ID: 3291301
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a sheep polyclonal antibody: II. Evaluation of the whole blood methodology and comparison with an 3H tracer-mediated radioimmunoassay with a sheep polyclonal antibody.
    Napoli KL; Kahan BD
    Transplant Proc; 1990 Jun; 22(3):1181-5. PubMed ID: 2190378
    [No Abstract]   [Full Text] [Related]  

  • 15. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
    Lim SH; Anantharaman V; Teo WS; Chan YH
    Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Yamazaki WM; Salgueiro MC; Silva ML; Ribeiro AC; Bezas AG
    Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality assessment of cyclosporine monitoring--Canadian validations.
    Wong PY; Mee AV; Glenn J; Keown PA
    Transplant Proc; 1990 Jun; 22(3):1216-7. PubMed ID: 2349683
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo fluorescence microscopy reveals cyclosporine G to be less nephrotoxic than cyclosporine A.
    Rooth P; Dawidson I; Diller K; Clothier N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):707-9. PubMed ID: 2966484
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of cyclosporine on renal hemodynamics and autoregulation in rats.
    Kaskel FJ; Devarajan P; Arbeit LA; Moore LC
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):603-9. PubMed ID: 3388504
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Hakala TR; Rosenthal JT; Carpenter BJ; Taylor RJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1728-9. PubMed ID: 3274417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.